Early induction of transforming growth factor-β via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats

Hypertension

Volumn 32, Issue 2, 1998, Pages 273-279

  Tomita, Hideharu ^a   Egashira, Kensuke ^a,b   Ohara, Yuichi ^a   Takemoto, Masao ^a   Koyanagi, Masamichi ^a   Katoh, Makoto ^a   Yamamoto, Hiroaki ^a   Tamaki, Kiyoshi ^a   Shimokawa, Hiroaki ^a   Takeshita, Akira ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiotensin II; Collagen; Endothelium derived relaxing factor; Growth substances; Remodeling

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; COLLAGEN; ENDOTHELIUM DERIVED RELAXING FACTOR; HYDRALAZINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; INFLAMMATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

EID: 0031814542     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.32.2.273     Document Type: Article

References (46)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
2. Dzau V, Gibbons G. Endethelium and growth factors in vascular remodeling of hypertension. Hypertension. 1991;24(suppl III):115-121.
3. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis. 1995;38:105-128.
4. Loscalzo J, Welch G. Nitric oxide and its role in the cardiovascular system. Prog Cardiovasc Dis. 1995;38:87-104.
5. Griendling KK, Alexander RW. Endothelial control of the cardiovascular system: recent advances. FASEB J. 1996;10:283-292.
6. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi H, Suzuki S, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993;91:29-37.
7. Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A. Effect of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation. 1993;88:77-81.
8. Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T, Takeshita A. Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Hypertension. 1995;25:201-206.
9. Zeiher AM, Drexler H, Saubier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effect of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest. 1993;92:652-662.
10. Ito A, Egashira K, Kadokami T, Fukumoto Y, Takayanagi T, Nakaike R, Kuga T, Sueishi K, Simokawa H, Takeshita A. Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation. 1995;92:2636-2644.
11. Numaguchi K, Egashira K, Takemoto M, Kadokami T, Shimokawa H, Sueishi K, Takeshita A. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension. 1995;26(pt 1):957-962.
12. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimowaka H, Sueishi K, Takeshita A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest. 1997;99:278-287.
13. Katoh M, Egashira K, Usui M, Ichiki T. Cardiac angiotensin II receptor is increased in rats with cardiac remodeling induced by long-term blockade of nitric oxide synthesis. Circulation. 1996;94(suppl I):I-656-I-657.
14. G-nitro-L-arginine methyl ester due to converting enzyme inhibition. J Cardiovasc Pharmacol. 1996;28:142-148.
15. Hinglais N, Heudes D, Nicoletti A, Mandet C, Laurent M, Bariety J, Michel JP. Colocalization of fibrosis and inflammatory cells in rats. Lab Invest. 1994;70:286-294.
16. Nicoletti A, Heudes D, Mandet C, Hinglais N, Bariety J, Michel JP. Inflammatory cells and duration in renovascular hypertensive rats. Cardiovasc Res. 1996;32:1096-1107.
17. Nicoletti A, Mandet C, Challah M, Bariety J, Michel JP. Mediators of perivascular inflammation in the left ventricle of renovascular hypertensive rats. Cardiovasc Res. 1996;31:585-595.
18. Weber KT, Brilla C. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83: 1849-1865.
19. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-β or platelet-derived growth factor gene into the rat kidney. J Clin Invest. 1993;92:2597-2601.
20. Sime PJ, Xing Z, Graham FL, Csaky KG, Gauldie J. Adenovirus-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J Clin Invest. 1997;100:768-776.
21. Border WA, Nobel NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
22. Ignotz RA, Massague J. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem. 1986;261:4337-4345.
23. Laiho M, Saksela O, Andreasen PA, Keski-Oja J. Enhanced production and extracellular deposition of the endothelial-type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol. 1986;103:2403-2410.
24. Boluyt OM, O'Neill L, Meredith LA, Bing HLO, Brooks WW, Conrad HC, Crow TM, Lakatta GE. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure: marked upregulation of genes encoding extracellular matrix components. Circ Res. 1994;75:23-32.
25. Takahashi N, Calderone A, Izzo JN, Marsh DJ, Colucci SW. Hypertrophic stimuli induce transforming growth factor-β1 expression in rat ventricular myocytes. J Clin Invest. 1994;94:1470-1476.
26. Villarreal JF, Dillmann HW. Cardiac hypertrophy-induced changes in mRNA levels for TGF-β1, fibronectin and collagen. Am J Physiol. 1992; 262:H1861-H1866.
27. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Circ Res. 1993;73:413-423.
28. Schorb WG, Booz W, Dostal DE, Conrad KM, Chang KC, Baker KM. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ Res. 1993;72:1245-1254.
29. Kagami S, Border AW, Millaer ED, Noble AN. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest. 1994;93:2431-2437.
30. Miyazono K, Ichijo H, Heldin CH. Transforming growth factor-β: latent form, binding proteins and receptors. Growth Factors. 1993;8:11-22.
31. Mizuno M, Sada T, Ikeda M, Fukuda N, Miyamoto M, Yanagisawa M, Koike H. Pharmacology of CS-866, a novel nonpeptide angiotensin II receptor antagonist. Eur J Pharmacol. 1995;285:181-188.
32. Tsuji T, Okada F, Yamaguchi K, Nakamura T. Molecular cloning of the large subunit of transforming growth factor type β masking protein and expression of the mRNA in various rat tissues. Proc Natl Acad Sci U S A. 1990;87:8835-8839.
33. Zhang K, Flanders KC, Phan SH. Cellular localization of transforming growth factor-β expression in bleomycin-induced pulmonary fibrosis. Am J Pathol. 1995;147:352-361.
34. Basile DP, Rovok JM, Martin DR, Hammerman MR. Increased transforming growth factor-β1 expression in regenerating rat renal tubules following ischemic injury. Am J Physiol. 1996;270:F500-F509.
35. Takemoto M, Egashira K, Tomita H, Usui M, Okamoto H, Kitabatake A, Shimokawa H, Sueishi K, Takeshita A. Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade: effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis. Hypertension. 1997;30:1621-1627.
36. Crawford D, Chobanian A, Brecher P. Angiotensin II induces fibronectin expression associated with cardiac fibrosis in the rat. Circ Res. 1994;74: 727-739.
37. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension. 1995;25:1252-1259.
38. 1 expression. Hypertension. 1994;23:587-592.
39. Tomita H, Egashira K, Inoue M, Takeya M, Yoshimura T, Takeshita A. Chronic inhibition of nitric oxide synthesis induces monocyte infiltration and myofibroblast formation in the rat heart. Circulation. 1997;96(suppl 1):I-492. Abstract.
40. Sun Y, Weber KT. Angiotensin-converting enzyme and myofibroblast during tissue repair in the rat heart. J Mol Cell Cardiol. 1996;28:851-858.
41. Sun Y, Weber KT. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res. 1996;31:518-525.
42. Campbell SE, Janicki JS, Weber KT. Temporal differences in fibroblast proliferation and phenotype expression in response to chronic administration of angiotensin II or aldosterone. J Mol Cell Cardiol. 1995;27: 1545-1560.
43. Khan BV, Harrison DG, Olbrych MT, Alexander RW, Medford RM. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. Proc Natl Acad Sci U S A. 1996;93:9114-9119.
44. Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ Res. 1995;76:980-986.
45. Niu XF, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res. 1994;74:1133-1140.
46. De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK. Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 1995;96:60-68.